Warfarin-Resistant Deep Vein Thrombosis during the Treatment of Acute Ischemic Stroke in Lung Adenocarcinoma

J Stroke Cerebrovasc Dis. 2016 Sep;25(9):e141-5. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.026. Epub 2016 Jun 22.

Abstract

Case report: A 66-year-old man with acute ischemic stroke in the setting of lung adenocarcinoma developed acute-onset deep vein thrombosis (DVT) of the lower limbs after changing to warfarin from a heparin combination. The diagnosis of warfarin-resistant DVT was established based on the laboratory data and clinical evaluation. Heparin administration resulted in good control of thrombin regulation. Cancer patients are at high risk of venous thromboembolism, and the combination of these 2 conditions is known as Trousseau's syndrome.

Conclusion: Our report suggests that heparin administration may provide good control of thromboembolic events, although there is no established medical treatment to extend the survival of patients with Trousseau's syndrome.

Keywords: Acute ischemic stroke; Trousseau's syndrome; deep venous thrombosis; heparin; lung cancer; warfarin.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / complications*
  • Adenocarcinoma / diagnostic imaging
  • Adenocarcinoma of Lung
  • Aged
  • Anticoagulants / adverse effects*
  • Diffusion Magnetic Resonance Imaging
  • Humans
  • Lung Neoplasms / complications*
  • Lung Neoplasms / diagnostic imaging
  • Male
  • Stroke / complications*
  • Tomography Scanners, X-Ray Computed
  • Venous Thrombosis / complications*
  • Venous Thrombosis / diagnostic imaging
  • Venous Thrombosis / drug therapy*
  • Warfarin / adverse effects*

Substances

  • Anticoagulants
  • Warfarin